Download:
pdf |
pdfPrint Date: 7/7/22
Title:
National HIV Behavioral Surveillance Brief HIV Biobehavioral Assessment project (NHBS-BHBA)
Project Id:
0900f3eb81f40989
Accession #:
NCHHSTP-BST-5/17/22-29c49
Project Contact:
Dafna Kanny
Organization:
NCHHSTP/DHP/BCSB/BST
Status:
Pending Regulatory Clearance
Intended Use:
Project Determination
Estimated Start Date:
01/01/2022
Estimated Completion Date:
12/31/2026
CDC/ATSDR HRPO/IRB Protocol #:
OMB Control #:
Determinations
Determination
Justification
HSC:
Does NOT Require HRPO
Review
Not Research - Public Health Surveillance
PRA:
PRA Applies
Completed
Entered By & Role
5/24/22
Dodson_Janella R. (jhd7) CIO HSC
6/1/22
Bonds_Constance (akj8) CTR OMB/PRA Coordinator
45 CFR 46.102(l)(2)
Description & Funding
Description
Priority:
Standard
Date Needed:
06/15/2022
Determination Start Date:
06/01/22
Description:
The National HIV Behavioral Surveillance system (NHBS) is a non-research surveillance system to monitor HIV prevention progress
(OMB #0920-0770, Exp. 01/31/2023). However, with efforts underway to end the HIV epidemic in the U.S., CDC#s Division of HIV
Prevention (DHP) recognized the need for additional rapid assessment data to inform local prevention efforts, especially in
geographic areas or populations which lack information on HIV risk behaviors. The National HIV Behavioral Surveillance system#s
Brief HIV Biobehavioral Assessment project (NHBS-BHBA) is designed to use mixed-methods assessments to meet this need. As
part of a new Notice of Funding Opportunity CDC-RFA-PS22-2201 to fund NHBS project areas (OMB #0920-0770, Exp. 01/31
/2023) (component 1), a new component (2) was awarded to 2 state health departments. An ICR packet has been submitted.
Funded state health departments for NHBS-BHBA will work with local entities to conduct brief bio-behavioral assessments (BHBA)
in priority populations throughout the state. Priority populations may include persons at highest risk for HIV: men who have sex with
men (MSM), persons who inject drugs (PWID), and heterosexually active persons at increased risk for HIV infection (HET), and
locally identified populations of interest (e.g., women who inject drugs and exchange sex, persons who use stimulants) or
geographic areas of interest (e.g., non-urban areas experiencing increased HIV incidence). The BHBA process includes 1)
identification of geographic areas/populations at risk, 2) formative assessment for operations, 3) brief mixed methods quantitative
and qualitative data collection and HIV testing, and 4) data analysis and dissemination, and development of grantee-developed
recommendations for state/local partners. NHBS-BHBA data may be used rapidly by public health officials and researchers to
develop specific and timely recommendations for state/local partners, respond to ongoing and emerging HIV hotspots, identify HIV
prevention and care needs, allocate prevention and treatment resources, and develop and improve prevention programs directed to
the populations of interest and their communities. Data will be shared with community partners and inform grantee-developed
recommendations for state and local public health partners.
IMS/CIO/Epi-Aid/Lab-Aid/Chemical Exposure
Submission:
No
IMS Activation Name:
Not selected
Primary Priority of the Project:
Not selected
Secondary Priority(s) of the Project:
Not selected
Task Force Associated with the Response:
Not selected
CIO Emergency Response Name:
Not selected
Epi-Aid Name:
Not selected
Lab-Aid Name:
Not selected
Assessment of Chemical Exposure Name:
Not selected
The goal of this project is to conduct brief bio-behavioral surveillance using mixed-methods assessments among priority populations
Goals/Purpose
Objective:
in specified geographic areas of interest across funded states. This surveillance system provides the opportunity to fill knowledge
gaps about HIV prevention among populations in geographic areas where data are limited and capitalize on experience recruiting atrisk individuals from non-healthcare community settings using scientifically sound methodologies. Data from these brief biobehavioral surveillance using mixed-methods assessments will be used for HIV prevention program planning and evaluation at the
state and local levels.
The objectives of NHBS-BHBA are to conduct ongoing monitoring to assess prevention and risk behaviors and HIV-associated
health outcomes in populations at high-risk for HIV, especially in geographic areas and populations where behavioral data are
limited. These data are critical for tracking the epidemic, planning effective responses, and monitoring and evaluating those
responses. The specific objectives are as follows: 1) Identify geographic areas with populations at increased risk of HIV infection. 2)
Assess the size of populations at risk for HIV infection. 3) Assess the prevalence of HIV infection. 4) Assess the prevalence of STI
infection or viral hepatitis (where appropriate, if funding is available). 5) Assess the prevalence of risk behaviors and social
determinants of health that increase the risk of HIV acquisition and transmission, including sexual risk behaviors and drug-use risk
behaviors. 6) Describe utilization of HIV testing, linkage to care, and antiretroviral therapy. 7) Assess the access to and use of
prevention services, including SSPs and PrEP. 8) Identify gaps in prevention services and missed opportunities for prevention
interventions.
Does this project include interventions, services, or No
policy change work aimed at improving the health of
groups who have been excluded or marginalized and
/or decreasing disparities?:
Project does not incorporate elements of health
equity science:
Not Selected
Measuring Disparities:
Yes
Studying Social Determinants of Health (SDOH):
Yes
SDOH Economic Stability:
Yes
SDOH Education:
Yes
SDOH Health Care Access:
Yes
SDOH Neighborhood and Environment:
Yes
SDOH Social and Community Context:
Yes
SDOH Indices:
Not Selected
Other SDOH Topics:
Not Selected
Assessing Impact:
Not Selected
Methods to Improve Health Equity Research and
Practice:
Yes
Other:
Not Selected
Activities or Tasks:
New Collection of Information, Data, or Biospecimens
Target Populations to be Included/Represented:
Other - Adults at high-risk for HIV in identified priority populations in specified geographic areas within
Tags/Keywords:
HIV ; bio-behavioral surveillance ; rapid assessments ; quantitative ; Qualitative Research ; mixed methods
CDC's Role:
Activity originated and designed by CDC staff, or conducted at the specific request of CDC, or CDC staff will approve study design
and data collection as a condition of any funding provided
Method Categories:
Focus Group; Individual Interviews (Qualitative); Prevalence (Cross-sectional) Surveys; Other - HIV Testing/collection of biospecimens
Methods:
NHBS-BHBAs are brief mixed-methods bio-behavioral HIV assessments conducted in priority populations in specified geographic
areas of interest (BHBA populations). The process includes 1) identification of geographic areas/populations at risk, 2) formative
assessment for operations, 3) quantitative and qualitative data collection and HIV testing, and 4) data analysis and dissemination.
State needs assessment activities include examining a comprehensive list of existing data sources to assess HIV prevention
priorities and develop a process to prioritize at least two populations to conduct BHBAs for each year of data collection. Project staff
will also establish community partnerships to support the project at the state and local levels. Project areas will conduct formative
assessment for each BHBA to identify appropriate recruitment methods and develop operational procedures in the project area.
Project areas will also garner the support of the local community and identify questions of local interest for HIV prevention.
Formative assessment will precede data collection. NHBS-BHBAs will be conducted through mixed-methods quantitative and
qualitative data collection. Project areas will implement recruitment strategies that may include venue based, time-space sampling
(VBS), respondent-driven sampling (RDS), and other CDC-approved methods to recruit populations at high-risk for HIV infection.
Project areas will conduct brief standardized quantitative interviews with eligible participants to meet the target sample size (n=500)
total participants from at least two BHBAs per year in funding years 2-5. Project areas will offer usually anonymous HIV blood-based
rapid testing and supplemental testing to those who participate in quantitative interviews to assess HIV seroprevalence. HIV
screening results will be made available to participants, and those with preliminary positive test results will be linked to HIV care.
Pending funding availability, HIV testing may include the collection of dried blood spot specimens for long term storage to conduct
additional testing, e.g., testing for recent HIV infection, HIV viral load, presence of antiretroviral drugs or pre-exposure prophylaxis,
or drug resistance. Other biological specimens may be collected and tested (e.g., viral hepatitis, sexually transmitted infections
(STI)) when funds are available. NHBS-BHBA rapid qualitative data collection include at least two forms of primary data collections,
including observations, key informant interviews with community members and professionals familiar with the population, focus
groups and other activities to interpret standardized quantitative findings and inform grantee-developed recommendations for state
/local public health partners. Small stipends or vouchers will be given to those interviewed and tested for HIV (approximately $25 for
each). In cycles using RDS, additional incentives (approximately $10) are paid to those who successfully recruit others. Funded
states will analyze and triangulate BHBA data to identify emerging key themes and recommendations and share preliminary findings
with their core and local advisory group comprised of community organizations and institutions that serve populations at high-risk of
HIV infection. They will develop a summary report for each BHBA with integrated findings from quantitative and qualitative data and
recommendations for state/local partners to inform HIV treatment and prevention.
Participants will be administered an eligibility screener; those who are eligible and give consent will be interviewed about sex and
drug use behaviors and their past HIV testing experiences using a standard questionnaire. The quantitative survey is administered
by trained interviewers using computers; HIV testing is done by trained staff. Other tests (e.g., new HIV testing technologies,
biological testing for STIs or hepatitis) may be performed in states that are funded to perform these activities. All participants will
provide their informed consent to take part in the interview, HIV testing, and any additional testing. 500 eligible persons from each
NHBS-BHBA funded state will be interviewed each year. The qualitative survey is administered by trained interviewers and a
minimum of 20 participants per BHBA population is expected. All participants will be informed during the recruitment process of the
anonymous nature of the data including the interview, HIV testing, and any additional testing offered. For participants# convenience
or benefit, participants may have the option to provide contact information to project staff on a voluntary basis. Examples of
participant convenience include but are not limited to: providing a phone number for phone text reminders of appointments;
providing payment information so incentives can be provided electronically; providing an email address to facilitate video conference
interviews; or providing an address to receive self-collection or self-testing kits via mail. Examples of participant benefit include but
are not limited to: providing a phone number so that project staff can call participants when their HIV/additional test results are
Collection of Info, Data or Biospecimen:
Expected Use of Findings/Results and their impact:
ready; providing contact information to help participants with linkage to HIV care or other services they may need. In all cases,
participants will be provided information and instructions for how to participate without providing contact information. This
surveillance activity is funded through cooperative agreements with participating health departments. All data will be collected
locally by grantees. No contact information will be sent to CDC. Project areas will keep contact information separately from all
NHBS-BHBA data and destroy contact information immediately upon completion of its intended use. Contact information will be
stored securely in a separate document from any NHBS-BHBA test result data, paper or electronic. In most cases, contact
information will not be linkable to any NHBS-BHBA data. In rare circumstance, contact information may need to be indirectly linkable
to limited NHBS-BHBA data, for example NHBS-BHBA project area staff cannot return test results by phone without both a phone
number and test result. A generated survey ID number will be used to link test results data or test kits for the purpose of returning
test results to participants or contacting participants to ensure a test kit is completed and returned. Consent forms, questionnaires,
lab forms, and other NHBS-BHBA data collection forms will be maintained in confidential secure environments and any hard copies
stored in locked filing cabinets. Only authorized persons will have access to NHBS-BHBA files. Audio recordings of qualitative
interviews and focus groups will be kept in a secure location that only authorized project staff can access and will be destroyed once
the information is transcribed and checked. Audio files will not be submitted to CDC.
Dissemination of findings is critical to the success of the project and funded states should use the data to inform and improve local
program efforts. Both quantitative and qualitative data should be analyzed, and findings, along with grantee-developed
recommendations, should be disseminated to local partners with the support of the core and local advisory groups. Funded states
will create a dissemination plan for each BHBA, including at least one data product or report and at least one presentation to
community partners. Funded states will have principal responsibility for analyzing their local quantitative and qualitative data and
developing tailored recommendations. NHBS-BHBA project areas and CDC may collaborate on articles and reports when
appropriate. Funded states will contribute to national reporting of data collection outcomes such as surveillance reports and other
publications by reviewing analysis notifications, concept proposals, table shells and manuscript drafts within specified timelines and
participating in discussions during monthly conference calls and annual meetings. CDC may disseminate reports, e.g., CDC HIV
Surveillance Special Reports and other CDC reports, the Morbidity and Mortality Weekly Report (MMWR), and peer-reviewed
journals. CDC may also present results at national conferences and meetings.
Could Individuals potentially be identified based on
Information Collected?
Yes
Will PII be captured (including coded data)?
Yes
Does CDC have access to the identifiers (including
coded data)?:
No
Is this project covered by an Assurance of
Confidentiality?
Yes
Assurances of Confidentiality associated with this
project:
NCHHSTP - AIDS and HIV Surveillance
Does this activity meet the criteria for a Certificate
of Confidentiality (CoC)?
No
Is there a formal written agreement prohibiting the
release of identifiers?
Yes, see supporting info
Funding
Funding Type
Funding Title
Funding #
Original Budget Yr
# Years Award
CDC Cooperative Agreement
National HIV Behavioral Surveillance (NHBS)
PS22-2201
2022
5
HSC Review
Regulation and Policy
Do you anticipate this project will be submitted to
the IRB office
No
Estimated number of study participants
Population - Children
Protocol Page #:
Population - Minors
Protocol Page #:
Population - Prisoners
Protocol Page #:
Population - Pregnant Women
Protocol Page #:
Population - Emancipated Minors
Protocol Page #:
Suggested level of risk to subjects
Do you anticipate this project will be exempt
research or non-exempt research
Requested consent process waviers
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Budget Amount
Parental permission
No Selection
Alteration of authorization under HIPPA Privacy
Rule
No Selection
Requested Waivers of Documentation of Informed Consent
Informed consent for adults
No Selection
Children capable of providing assent
No Selection
Parental permission
No Selection
Consent process shown in an understandable language
Reading level has been estimated
No Selection
Comprehension tool is provided
No Selection
Short form is provided
No Selection
Translation planned or performed
No Selection
Certified translation / translator
No Selection
Translation and back-translation to/from target
language(s)
No Selection
Other method
No Selection
Clinical Trial
Involves human participants
No Selection
Assigned to an intervention
No Selection
Evaluate the effect of the intervention
No Selection
Evaluation of a health related biomedical or
behavioral outcome
No Selection
Registerable clinical trial
No Selection
Other Considerations
Exception is requested to PHS informing those
bested about HIV serostatus
No Selection
Human genetic testing is planned now or in the
future
No Selection
Involves long-term storage of identfiable biological
specimens
No Selection
Involves a drug, biologic, or device
No Selection
Conducted under an Investigational New Drug
exemption or Investigational Device Exemption
No Selection
Institutions & Staff
Institutions
Name
FWA #
FWA Exp Date
IRB Title
IRB Exp Date
Florida Department of Health
Funding #
PS22-2201
Massachusetts Department of Public Health
FWA00000786
03/04/25
PS22-2201
Staff
Staff Member
SIQT
Exp. Date
CITI Biomedical
Exp. Date
CITI Social &
Behavioral Exp. Date
CITI Good Clinical
Practice Exp. Date
Staff Role
Email
Phone
Organization
Statistician
404-6391956
BEHAVIORAL SURVEILLANCE TEAM
Amy Baugher
12/27
/2024
Catlainn Sionean
09/20
/2024
Program
Official
404-6392
BEHAVIORAL SURVEILLANCE TEAM
Christine Agnew
Brune
06/05
/2023
Project
Officer
404-7185478
BEHAVIORAL SURVEILLANCE TEAM
Cyprian Wejnert
02/22
/2025
Program
Lead
404-6396055
BEHAVIORAL AND CLINICAL
SURVEILLANCE BRANCH
Dita Broz
08/11
/2023
Program
Official
404-6395258
BEHAVIORAL SURVEILLANCE TEAM
Ebony Symone
Townsend
01/12
/2024
Project
Officer
404-4984180
BEHAVIORAL SURVEILLANCE TEAM
12/07
Project
404-718-
09/06/2021
02/07/2021
Elana Morris
/2024
Officer
8193
BEHAVIORAL SURVEILLANCE TEAM
Janet Burnett
06/08
/2023
Project
Officer
404-6390086
BEHAVIORAL SURVEILLANCE TEAM
Jeffery Todd
02/28
/2023
Project
Officer
404-7185389
BEHAVIORAL SURVEILLANCE TEAM
Johanna ChapinBardales
08/04
/2023
Statistician
404-7185879
BEHAVIORAL SURVEILLANCE TEAM
Kathryn Lee
08/10
/2023
Program
Official
404-6396110
BEHAVIORAL SURVEILLANCE TEAM
Lyssa Faucher
06/08
/2024
Project
Officer
404-7182086
BEHAVIORAL SURVEILLANCE TEAM
Paul Denning
08/11
/2023
Project
Officer
404-6393
BEHAVIORAL SURVEILLANCE TEAM
Rashunda Lewis
03/20
/2023
Program
Official
404-6392981
BEHAVIORAL SURVEILLANCE TEAM
Susan Cha
12/30
/2024
Project
Officer
404-7185486
BEHAVIORAL SURVEILLANCE TEAM
Taylor Robbins
06/14
/2023
Project
Officer
404-6390016
BEHAVIORAL SURVEILLANCE TEAM
Teresa Finlayson
01/03
/2023
Program
Official
404-6392083
BEHAVIORAL SURVEILLANCE TEAM
12/18/2018
08/16/2019
Data
DMP
Proposed Data Collection Start Date:
1/1/23
Proposed Data Collection End Date:
12/31/26
Proposed Public Access Level:
Restricted
Restricted Details:
Data Sharing Agreement
Data Use Type:
Data Use Type URL:
Data Use Contact:
nhbs@cdc.gov
Public Access Justification:
As a component of HIV/AIDS surveillance, NHBS data are protected by the Assurance of Confidentiality (Section 308(d) of the
Public Health Service Act, 42 U.S.C. 242 m(d)). This assurance prohibits the disclosure of any information that could be used to
directly or indirectly identify individuals. HIV and hepatitis surveillance data require additional protection. Therefore, data collection,
management and analysis for this project will be conducted in compliance with the Centers for Disease Control and Prevention#s
Data Security and Confidentiality Guidelines for HIV, Viral Hepatitis, Sexually Transmitted Disease, and Tuberculosis Programs:
Standards to Facilitate Sharing and Use of Surveillance Data for Public Health Action available at http://www.cdc.gov/nchhstp
/programintegration/docs/PCSIDataSecurityGuidelines.pdf
How Access Will Be Provided for Data:
Processes for accessing NHBS data are described in the NHBS Multi-site Data Sharing Guidance document (Attached).
Plans for Archival and Long Term Preservation:
Spatiality
Country
State/Province
United States
Massachusetts
United States
Florida
County/Region
Dataset
Dataset
Title
Dataset
Description
Dataset yet to be added...
Supporting Info
Data Publisher
/Owner
Public Access
Level
Public Access
Justification
External
Access URL
Download
URL
Type of Data
Released
Collection
Start Date
Collection End
Date
Current
CDC Staff
Member and
Role
Date Added
Description
Supporting Info Type
Supporting Info
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
NHSS Assurance packet, including
a non-disclosure agreement and
an agreement to abide by
restrictions of data release
Non Disclosure Agreement
NHSS_FTE-Packet_FinJuly2020-508_compliant.pdf
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
NCHHSTP_PRA Determination
Form BHBA
Paperwork Reduction Act Form
NCHHSTP_PRA Determination Form BHBA_final.doc
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
Model Qualitative FG Consent
Form
Consent Form
Appendix G Model Qualitative FG Consent Form-final.
docx
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
Model Qualitative PKI Consent
Form
Consent Form
Appendix E Model Qualitative PKI Consent Form-final.
docx
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
NHBS-BHBA Protocol
Protocol
Protocol_Full_20220517_STARS submit.docx
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
Model Survey Consent Form
Consent Form
Appendix I Model Survey Consent Form-final.docx
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
Model Qualitative CKI Consent
Form
Consent Form
Appendix F Model Qualitative CKI Consent Form-final.
docx
Current
Kanny_Dafna
(dkk3)
Project Contact
05/17/2022
NHBS Multi-site Data Sharing
Guidance
Data Use Agreement
NHBS Multi-site Data Sharing Guidance 04122022.pdf
File Type | application/pdf |
File Modified | 0000-00-00 |
File Created | 2022-07-07 |